We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/6/2018 12:50 | Will buy more into close. Weekend press coverage or news could light the blue touch paper under this. | the stigologist | |
15/6/2018 12:45 | Welcome to the club and with such rock stars on the board now, I have a very excellent feeling. | k1ngkonggb | |
15/6/2018 12:44 | Yes - bought a few. Will look to add more soon. | someuwin | |
15/6/2018 12:35 | Get in, it would be rude not to!!! | k1ngkonggb | |
15/6/2018 12:14 | Thanks for the heads up on this on the SEE thread Brucie. This does indeed look highly mispriced. * Proven IP with many years history of clinical usage * New business plan with new products being developed with industry partners * Miton taking almost 9% * Options set at £3. * Broker target £4. * Currently only £6m maket cap. | someuwin | |
15/6/2018 08:33 | Good posts, just wanted to say... Keep up the good work. | brucie5 | |
15/6/2018 08:26 | Good call Stig. I will work on one when I get a moment. | bones | |
15/6/2018 08:06 | Let's have another good day | turbotrader2 | |
15/6/2018 04:56 | I don't think the header of this thread is fit for purpose any longer. Anyone willing to take it upon themselves to start a new thread for this new era? | the stigologist | |
14/6/2018 22:27 | Volume was significant at over 10% of the old company, and 4% of the enlarged share capital.Stale holders gradually being washed through. | bones | |
14/6/2018 21:25 | Possibly significant breakout on volume today On the longer term chart you can see why there is potential to gap up very quickly towards 400p | the stigologist | |
14/6/2018 16:49 | Yes, Stig, excellent points. I am impressed by what I see here! | bones | |
14/6/2018 16:22 | What's quite striking to me and probably not fully appreciated by the market is the amount of M&A activity in this space with massive US MedTechs taking 'punts' on early/development stage VC/Private companies. This market is really wide open right now. Further I don't think i've ever seen a small company in the tech world with this opportunity rich environment in front of it but tooled up so well in terms of staff, partners and IP. Incredible really. | the stigologist | |
14/6/2018 15:06 | Tick tock indeed | turbotrader2 | |
14/6/2018 14:55 | At some point the market will be aware of the potential and there will be no more weak hands selling. Will then get gapped up pretty quickly. Just a matter of time. | the stigologist | |
14/6/2018 13:12 | Anyway I've added twice today I'm very excited after a long period of frustration which has clearly been worth the wait for me | turbotrader2 | |
14/6/2018 13:09 | No worries, TT. I was under the impression we had already had a "big" announcement! | bones | |
14/6/2018 13:06 | BonesI was only saying what someone said | turbotrader2 | |
14/6/2018 13:01 | Only idiots post on Lunatic Asylum | the stigologist | |
14/6/2018 12:28 | LOL, that one liner from the LSE thread is not fit to be called a rumour! Let's keep it relevant over here if we can and back it up with something? | bones | |
14/6/2018 12:02 | Rumours of announcement (big) according to a poster on LSE | turbotrader2 | |
14/6/2018 11:54 | Just bought another 5k, this is so under valued !!!! | joeblogg2 | |
14/6/2018 11:50 | Repeated 25k blocks Interesting | turbotrader2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions